Up next

Autoplay

Dr. Humphrey on Mogamulizumab for Cutaneous T-Cell Lymphoma

1 Views • 08/09/23
Share
Embed
administrator
administrator
Subscribers
0

Jeffrey Humphrey, MD, president, Kyowa Hakko Kirin Pharma, Inc., discusses the benefits of mogamulizumab for the treatment of cutaneous T-cell lymphoma.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay